Workshops
IPVC 2021 workshops will focus on this year’s theme, “Research and education for HPV elimination”. They will provide state-of-the-art knowledge on all papillomavirus (PV)-related topics, from basic science to global health impact.
Workshops will be run by and have speakers who are worldwide leaders in the field. They will provide a unique forum for education and discussion, for the full spectrum of professional audiences – junior through senior researchers; basic scientists, clinicians and public health investigators.
At IPVC 2021, the pre-conference workshops will be made up of two parts:
- The first day will start with an interdisciplinary workshop, consisting of a series of talks covering key aspects of basic science, clinical and public health, with plenty of opportunities for discussion and audience interaction.
- Afterwards, attendees will be able to join one of the three tracks – Basic Science, Clinical Science or Public Health, Epidemiology and Implementation Science – where specific topics of contemporary interest will be covered. A particular emphasis will be given to discussion on controversial areas of research and on experiences across different populations. In all sessions, audience interaction will be prioritized.
Monday, November 15, 2021
Click on the sections below to learn more about the workshops. Please note the information might be subject to change.
10:00 AM – 11:30 AM EST (GMT-5)
Moderator:
Silvia de Sanjosé, Spain
Presentations:
- High risk HPV infection – the molecular road to cancer
Karl Munger, USA - HPV-specific medical therapies- prospects and challenges
Jacques Archambault, Canada - Increased burden of HPV cancers: another collateral damage of the COVID-19 pandemic?
Karen Canfell, Australia - On the road to cervical cancer elimination: obstacles, challenges and opportunities
Ophelia Ginsburg, USA
12:00 PM – 01:30 PM EST (GMT-5)
BASIC SCIENCE WORKSHOP 01: THE BIOLOGY OF HUMAN PAPILLOMAVIRUS DISEASE AT THE CERVIX
Chair:
John Doorbar, UK
Presentations:
- The Cervical Transformation Zone – Understanding Disease Pathology at a Vulnerable Epithelial Site
Olaf Reich, Austria
-
HPV Deregulation and the Pathways towards Cervical Neoplasia and Cancer
John Doorbar, UK
-
Immune Control of Human Papillomavirus – Current Thinking and Gaps in Our Knowledge
John Schiller, USA -
Factors Influencing Cervical Cancer Progression Risk. Key Perspectives from the Epidemiologist
Mark Schiffman, USA
02:00 PM – 03:30 PM EST (GMT-5)
BASIC SCIENCE WORKSHOP 02: VIRUS ENTRY AND TRAFFICKING
Chair:
John Doorbar, UK
Presentations:
-
HPV16 Pseudovirus Infection is Blocked by a Peptide Derived from Sorting Nexin-1
Samuel K. Campos, USA -
Going fishing with HPV during virus entry
Dan DiMaio, USA -
HPV16 uptake by WASH-mediated endocytosis (WASH-ME)
Mario Schelhaas, Germany
-
Nuclear delivery of HPV16 capsids
Patricia Day, USA -
Nuclear phospholipases facilitate HPV16 infection
Martin Sapp, USA
04:00 PM – 05:30 PM EST (GMT-5)
BASIC SCIENCE WORKSHOP 03: GENOME STRUCTURE AND EXPRESSION
Chairs:
Alison McBride, USA
Joanna Parish, UK
Presentations:
- Dynamic expression of the diversified papillomavirus genomes
Zhi-Ming Zheung, USA - Genome-wide epigenetic modifications in papillomavirus genome expression
Joanna Parish, UK - RNA-cis elements in papillomavirus RNA splicing and gene expression
Stefan Schwartz, Sweden - Integrated HPV genome structure and clonal selection
Dr. Lulu Yu, USA
12:00 PM – 01:30 PM EST (GMT-5)
CLINICAL SCIENCE WORKSHOP 01: UPDATE ON EPIDEMIOLOGY OF HPV-RELATED CANCER AND PRE-CANCER
Chairs:
Silvia de Sanjose, Spain
Ashish Deshmukh, USA
Presentations:
- Updates in the epidemiology of cervical cancer and pre-cancer
Silvia de Sanjose, Spain - Updates in the epidemiology of head and neck cancer and pre-cancer
Gypsyamber (Amber) D’Souza, USA - Updates in the epidemiology of anal cancer and pre-cancer
Ashish Deshmukh, USA - Updates in the epidemiology of other HPV-related cancers
Gary Clifford, France - Debate – It is time to change cervical screening practices for women who have been vaccinated against HPV?
2:00 PM – 03:30 PM EST (GMT-5)
CLINICAL SCIENCE WORKSHOP 02: EMERGING APPROACHES TO IMMUNOTHERAPY OF PRE-CANCER AND CANCER
Chair:
Mark Einstein, USA
Presentations:
- TBC
Peter Stern, UK - Update on therapeutic vaccines
Andrew (Andy) G. Sikora, USA - Therapeutic uses of prophylactic HPV vaccines
John Schiller, USA - Role of checkpoint inhibitors
Mark Einstein, USA - Debate – Immunotherapy is better targeted at invasive cancer than high-grade squamous intraepithelial lesions
Pro: Sjoerd van der Burg, The Netherlands
Con: Kees Cornelis Melief, The Netherlands
04:00 PM – 04:50 PM EST (GMT-5)
CLINICAL SCIENCE WORKSHOP 03: DIAGNOSIS AND MANAGEMENT OF HPV-RELATED DISEASE IN THE IMMUNOCOMPROMISED PATIENT
Chairs:
Joel Palefsky, USA
Meredith Shiels, USA
Presentations:
- Epidemiology of HPV-related cancer in the immunocompromised host
Meredith Shiels, USA - Diagnosis of HPV-related disease in the immunocompromised patient: special considerations
Richard Hillman, Australia - Management of HPV-related disease in the immunocompromised patient: special considerations
Elizabeth Stier, USA - Vaccination for prevention and treatment of the immunocompromised patient: special considerations
Joel Palefsky, USA
12:00 PM – 01:30 PM EST (GMT-5)
PUBLIC HEALTH WORKSHOP 01: VACCINATION
Chair:
Julia Brotherton, Australia
Presentations:
- State of the art in vaccine coverage
Paul Bloem, Switzerland - Debate: Gender neutral vaccination
Pro: Iacobo Bausano
Con: Helen Riess, USA - Measuring impact in LMIC: the importance of information and surveillance systems
Raúl Murillo, Colombia - New prophylactic vaccines
Peter Dull, USA - Panel: One dose vs two doses
Scott D. Lamontagne
Deborah Watson-Jones, UK
Aimée Kreimer, USA
02:00 PM – 03:30 PM EST (GMT-5)
PUBLIC HEALTH WORKSHOP 02: SCREENING
Chair:
Mark Steben, Canada
Presentations:
- Self-sampling
Gina Ogilvie, Canada - Comprehensive coverage
Laia Bruni, Spain - Triage strategies in LMIC: should we use risk-based management?
Mark Schiffman, USA - Reaching unreached population
Aisha Lofters, Canada - Treatment issues
Michael Chang
04:00 PM – 04:50 PM EST (GMT-5)
PUBLIC HEALTH WORKSHOP 03: INFORMATION AND EDUCATION
Chair:
Ana Cecilia Rodriguez, USA
Presentations:
- Vaccinating against misinformation
Heidi Larson, UK - Preparing stakeholders before introduction of HPV-testing
Silvina Arrossi, Argentina - Complex system approach as optimal strategy for control?
Patti Gravitt, USA
Tuesday, November 16, 2021
Click on the sections below to learn more about the workshops. Please note the information might be subject to change.
10:30 AM – 12:00 PM EST (GMT-5)
BASIC SCIENCE WORKSHOP 04: REPLICATION
Chairs:
Alison McBride, USA
Joanna Parish, UK
Presentations:
- Viral factors and HPV replication
Dr. Iain Morgan, UK - The role of the DDR and epigenetic factors in HPV replication
Cary Moody, USA - Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
Lisa Mirabello, USA
12:30 PM – 14:00 PM EST (GMT-5)
BASIC SCIENCE WORKSHOP 05: MOLECULAR BASIS OF ANTI–VIRALS FOR HPV
Chairs:
Michelle Ozbun, USA
Prof. Sheila Graham, UK
Presentations:
-
Therapeutic vaccines
Martin Kast, USA -
Viral replication
Alison McBride, USA -
Innate immune response
Marisa Gariglio, Italy -
Cell signalling
Andrew MacDonald, UK
10:30 AM – 12:00 PM EST (GMT-4)
CLINICAL SCIENCE WORKSHOP 04: EMERGING CONCEPTS IN PATHOGENESIS AND DIAGNOSIS OF HPV-RELATED CANCER AND PRE-CANCER
Chairs:
Robert Burk, USA
Nicolas Wentzensen, USA
Presentations:
- Role of microRNAs and incRNAs in pathogenesis of HPV-related disease
Thomas Zheng, USA - Role of microbiome in pathogenesis of HPV-related disease
Maria Kyrgiou, UK - Artificial Intelligence-Based Triage Strategies: Dual Stain and Automated Visual Evaluation
Nicolas Wentzensen, USA - DNA sequencing for detection of HPV
Lisa Mirabello, USA - Methylation panel discussion
Robert Burk, USA
Attila Lorincz, UK
Renske Steenbergen, The Netherlands
12:30 PM – 02:00 PM EST (GMT-4)
CLINICAL SCIENCE WORKSHOP 05: HPV PROPHYLACTIC VACCINATION UPDATE
Chair:
Margaret Stanley, UK
Francesc Xavier Bosch, Spain
Presentations:
- Trends in vaccine uptake: impact of the Covid pandemic
Francesco Xavier Bosch, Spain - Impact of HPV vaccination on cervical cancer, pre-cancer and HPV
Marc Brisson, Canada - Durability of HPV vaccine response
Anna Giuliano, USA - New vaccine candidates
Richard Roden, USA - Debate: Gender neutral vaccination should be standard in all countries where HPV vaccination is standard of care for females
Pro: Margaret Stanley, UK
Con: John Schiller, USA
10:30 PM – 12:00 PM EST (GMT-4)
PUBLIC HEALTH WORKSHOP 04: COMBINATION STRATEGIES
Chair:
Louise Kuhn, USA
Presentations:
- Considerations for the adequate clinical assessment of AI based approaches in image evaluation
Kanan Desai, USA - Combined strategy for cervical cancer control: Even Faster program
Joakim Dillner, Sweden - HIV, Female genital schistosomiasis and bacterial vaginosis: cervical cancer forgotten companions?
Peter Hotez, USA - Is there a place for services integration?
Ruanne Barnabas, USA - Financing HPV testing and thermocoagulation
Owen Demke, Rwanda
12:30 PM – 02:00 PM EST (GMT-4)
PUBLIC HEALTH WORKSHOP 05: FORGOTTEN ISSUE IN THE CERVICAL ELIMINATION DRIVE
Chair:
Marc Steben, Canada
Presentations:
- Upgrading surgical capacities for cancer treatment in LMIC
Partha Basu, France - Upgrading chemotherapy capacities in LMIC
Neerja Bhatla, India - Upgrading radiotherapy capacities in LMIC
Surbhi Grover, USA - Introduction of palliative care as integral part of cervical cancer elimination drive
Eduardo D. Bruera, USA - Call to action
Silvia de Sanjose, USA
Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main conference, where the latest knowledge in research will be presented. For junior scientists, the workshops will help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology, and prevention and control of papillomavirus infection and disease.
IPVC 2021 workshops will be a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.
Please, note that there is an additional fee to attend the workshops and a pre-registration is required. For more information, visit the registration page.
If you have already registered and you wish to book a spot at the workshop, please contact reg_ipvc21@kenes.com